CD8A and neoplasm: The presence of tumors was monitored in individual animals using in vivo bioluminescence imaging so that mice that rejected tumors could be excluded from the analysis, thus ensuring that only CD8+ T cells that had been continually exposed to tumor antigens were analyzed.